|Bid||0.0000 x 2200|
|Ask||0.0000 x 800|
|Day's Range||1.7000 - 1.9100|
|52 Week Range||1.7000 - 15.8000|
|Beta (5Y Monthly)||1.43|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 22, 2023 - Feb 27, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||20.20|
SAN MATEO, Calif. and CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today announced that members of the management team will participate in fireside chats at the following investor conferences: Piper Sandler’s 34th Annual Healthcare Conference on Tuesday, November 29, 2022, at 11:30 a.m. ET; andEvercore ISI’s 5th Annual HealthCONx on Thursday, December 1, 2022, at 1 p.m. ET. The fire
Kronos Bio, Inc. (KRON) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
The recent price decline of 11% in Kronos Bio, Inc.'s ( NASDAQ:KRON ) stock may have disappointed insiders who bought...